Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis

被引:83
作者
Overeem, S
Dalmau, J
Bataller, L
Nishino, S
Mignot, E
Verschuuren, J
Lammers, GJ
机构
[1] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands
[2] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA
[3] Univ Hosp La Fe, Dept Neurol, Valencia, Spain
[4] Stanford Univ, Ctr Narcolepsy, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA
关键词
D O I
10.1212/01.WNL.0000101718.92619.67
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Idiopathic narcolepsy is associated with deficient hypocretin transmission. Narcoleptic symptoms have recently been described in paraneoplastic encephalitis with anti-Ma2 antibodies. The authors measured CSF hypocretin-1 levels in six patients with anti-Ma2 encephalitis, and screened for anti-Ma antibodies in patients with ideopathic narcolepsy. Anti-Ma autoantibodies were not detected in patients with idiopathic narcolepsy. Four patients with anti-Ma2 encephalitis had excessive daytime sleepiness; hypocretin-1 was not detectable in their cerebrospinal fluid, suggesting an immune-mediated hypocretin dysfunction.
引用
收藏
页码:138 / 140
页数:3
相关论文
共 10 条
[1]  
Black JL, 2002, SLEEP, V25, P719
[2]   The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias [J].
Mignot, E ;
Lammers, GJ ;
Ripley, B ;
Okun, M ;
Nevsimalova, S ;
Overeem, S ;
Vankova, J ;
Black, J ;
Harsh, J ;
Bassetti, C ;
Schrader, H ;
Nishino, S .
ARCHIVES OF NEUROLOGY, 2002, 59 (10) :1553-1562
[3]   Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy [J].
Nishino, S ;
Ripley, B ;
Overeem, S ;
Nevsimalova, S ;
Lammers, GJ ;
Vankova, J ;
Okun, M ;
Rogers, W ;
Brooks, S ;
Mignot, E .
ANNALS OF NEUROLOGY, 2001, 50 (03) :381-388
[4]   Narcolepsy: Clinical features, new pathophysiologic insights, and future perspectives [J].
Overeem, S ;
Mignot, E ;
van Dijk, JG ;
Lammers, GJ .
JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2001, 18 (02) :78-105
[5]   A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains [J].
Peyron, C ;
Faraco, J ;
Rogers, W ;
Ripley, B ;
Overeem, S ;
Charnay, Y ;
Nevsimalova, S ;
Aldrich, M ;
Reynolds, D ;
Albin, R ;
Li, R ;
Hungs, M ;
Pedrazzoli, M ;
Padigaru, M ;
Kucherlapati, M ;
Fan, J ;
Maki, R ;
Lammers, GJ ;
Bouras, C ;
Kucherlapati, R ;
Nishino, S ;
Mignot, E .
NATURE MEDICINE, 2000, 6 (09) :991-997
[6]   CSF hypocretin/orexin levels in narcolepsy and other neurological conditions [J].
Ripley, B ;
Overeem, S ;
Fujiki, N ;
Nevsimalova, S ;
Uchino, M ;
Yesavage, J ;
Di Monte, D ;
Dohi, K ;
Melberg, A ;
Lammers, GJ ;
Nishida, Y ;
Roelandse, FWC ;
Hungs, M ;
Mignot, E ;
Nishino, S .
NEUROLOGY, 2001, 57 (12) :2253-2258
[7]   Molecular and clinical diversity in paraneoplastic immunity to Ma proteins [J].
Rosenfeld, MR ;
Eichen, JG ;
Wade, DF ;
Posner, JB ;
Dalmau, J .
ANNALS OF NEUROLOGY, 2001, 50 (03) :339-348
[8]   The neurobiology, diagnosis, and treatment of narcolepsy [J].
Scammell, TE .
ANNALS OF NEUROLOGY, 2003, 53 (02) :154-166
[9]   Reduced number of hypocretin neurons in human narcolepsy [J].
Thannickal, TC ;
Moore, RY ;
Nienhuis, R ;
Ramanathan, L ;
Gulyani, S ;
Aldrich, M ;
Cornford, M ;
Siegel, JM .
NEURON, 2000, 27 (03) :469-474
[10]   A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer [J].
Voltz, R ;
Gultekin, SH ;
Rosenfeld, MR ;
Gerstner, E ;
Eichen, J ;
Posner, JB ;
Dalmau, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (23) :1788-1795